Indberetningsfrekvensen for rhabdomyolyse for 0, 8 mg er væsentlig større end frekvensen for 0, 4 mg og lavere doser.
Reporting rates of rhabdomyolysis with the 0.8mg dose were greatly in excess of those seen with both the 0.4mg and lower doses.